Clinical TrialsSearch results
Number of results: 334
Other
- A multi institutional phase II study of oral fludarabine and rituximab (F-R therapy) for patients with relapsed or refractory mantle cell lymphoma.
- Mantle cell lymphoma
- Hematological Malignancy Clinical Study Group
- 2008-10-11
Other
- A phase2 study of Rituximab+THP-COP(R-THP-COP) in elderly subjects with untreated, advanced, CD20-positive, indolent B-cell Non-Hodgkin's lymphoma
- indolent B-cell lymphoma
- Hematological Malignancy Clinical Study Group
- 2009-08-03
Other
- A Phase II trial of S-1 and concurrent radiotherapy for locally advanced pancreatic cancer
- Locally advanced pancreatic cancer
- Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital
- 2006-09-12
Recruiting
- Additional effect of luseogliflozin on semaglutide for non-alcoholic steatohepatitis patients with type 2 diabetes
- Nonalcoholic steatohepatitis
- Hiasa Yoichi
- 2021-06-03
Recruiting
- Clinical trial of therapeutic vaccine against chronic hepatitis B patients under NAs treatment
- chronic hepatitis B
- Hiasa Yoichi
- 2022-03-22
Recruiting
- Clinical trial of therapeutic vaccine against HBV carriers without anti-HBV treatment
- chronic hepatitis B
- Hiasa Yoichi
- 2022-03-22
Completed
- Clinical trial of HB vaccine against HBV infection
- HBV infection
- Hiasa Yoichi
- 2019-03-25
Completed
- Clinical trial retreatment by therapeutic vaccine against HBV
- Chronic hepatitis B
- Hiasa Yoichi
- 2020-07-10
Recruiting
- CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease
- Breast Cancer, Early Breast Cancer
- Hibi Kazushige
- 2023-11-11
Other
- Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) Study: Prospective Randomized Open-label Blinded Endpoint (PROBE)
- Untreated essential hypertensive patients
- HOMED-BP Study Group
- 2005-09-09